ABOUT HEART FAILURE
Over 25 MILLION LIVING WITH HEART FAILURE WORLDWIDE,
SEVERAL MILLION NEW DIAGNOSES EACH YEAR
Heart failure does not mean your heart has stopped working. Heart failure is a condition in which the heart cannot pump enough blood to meet your body’s needs. If you or a loved one have heart failure, you are not alone. Over 25 million people worldwide have this condition with several million new diagnoses per year.
GETTING TO KNOW YOUR HEART
The heart is a fist-sized organ that acts as a pump to send oxygen-rich blood throughout the body. In a healthy heart, each chamber contracts (squeezes) in a coordinated effort –
the upper chambers (atria) of the heart contract first, then the lower chambers (ventricles) contract. These coordinated
contractions circulate blood between the lungs and heart and to the rest of the body.
THE FAILING HEART
During heart failure, the heart attempts to compensate for lost pumping power, and the heart may change its shape and result in an uncoordinated and inefficient heartbeat.
The walls of the heart become thin, and the chambers become enlarged, making the heart weak and inefficient
EVEN WITH CURRENTLY AVAILABLE TREATMENT
HEART FAILURE CAUSES
Heart failure is typically a progressive condition, meaning it worsens and shortens life expectancy. There is no single cause, and sometimes the cause is unknown. Some of the most common causes of heart failure are:
Coronary artery disease
High blood pressure
Defective heart valves
Heart infection (i.e., virus)
Illicit drug use
HEART FAILURE SYMPTOMS
At first you might not experience any symptoms. However, over time you may experience some, or all, of the following symptoms:
Chronic lack of energy
Interrupted sleep at night due to breathing difficulties
Confusion and/or impaired memory
Increased urination at night
Swelling of feet and legs
Shortness of breath
Abdominal swelling or tenderness with loss of appetite
Cough with saliva/mucus
1.Card Fail Rev. 2017 Apr; 3(1): 7–11. doi: 10.15420/cfr.2016:25:2.
2. Blecker S, Agarwal SK, Chang PP, et al. Quality of care for heart failure patients hospitalized for any cause. J Am Col Cardiol. 2014;63(2):123-30.
LivaNova USA, Inc.
100 Cyberonics Boulevard
Houston, TX 77058
IMPORTANT SAFETY INFORMATION
INDICATIONS FOR USE (EUROPE)
Autonomic regulation therapy (ART) is indicated for patients who have moderate to severe heart failure (NYHA Class II/III) with left ventricular dysfunction (EF ≤ 40%), and who remain symptomatic despite stable, optimal heart failure drug therapy.
CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS
The VITARIA® System cannot be used on patients with a bilateral vagotomy.
The VITARIA System cannot be used on patients with a history of AV block.
Do not use shortwave diathermy, microwave diathermy, or therapeutic ultrasound diathermy on patients implanted with a VITARIA System. Diagnostic ultrasound is not included in this contraindication.
Magnetic Resonance Imaging (MRI) - The VITARIA System is an MR Conditional device that has been
shown to pose no known hazards in a specific MR environment with specified conditions for use. For specific conditions, refer to the VITARIA Physician's Manual. Patients with existing ulcers (gastric, duodenal or other) may have their condition aggravated by ART. Patients with ulcers should be evaluated prior to implantation and monitored following initiation of stimulation. Potential surgery-related adverse events include hematoma, infection, pain and voice alteration (hoarseness). Potential stimulation-related adverse events include dyspepsia (indigestion), dysphagia (difficulty swallowing), dyspnea (difficulty breathing, shortness of breath), increased coughing, laryngismus (throat, larynx spasms), pain, paresthesia (prickling of the skin), pharyngitis (inflammation of the pharynx, throat), satiety (reduced appetite), sensation of stimulation, and voice alteration (hoarseness).